Culture

New 3D maps reveal inner workings of immune cell gene expression

image: Enhancers serve as specific switches that turn on genes in a cell specific manner but it has been difficult to determine which switch is connected to which gene.

Image: 
Alex Fung

LA JOLLA--The COVID-19 pandemic has highlighted how our small genetic differences can have a tremendous effect on how our bodies respond to disease.

"The difference is within us," says Vivek Chandra, Ph.D., an instructor at La Jolla Institute for Immunology (LJI). "We can get infected by the same bacteria or viruses, but the ways our diseases progress can be very different."

Genetic variations are important, but there's more to the puzzle. To truly understand how genes affect health, researchers need to track down the switches (also called "enhancers") that control when and where a gene is expressed in the body.

Now researchers at La Jolla Institute for Immunology (LJI) have created 3D maps of how enhancer sequences and genes interact in several types of immune cells. Their new study in Nature Genetics opens the door to understanding individual risk for diseases from asthma to cancer.

"Nobody has done this mapping, either technically or analytically, to this precision in immune cells," says LJI Associate Professor Pandurangan Vijayanand M.D., Ph.D., co-senior author of the new study.

"Going forward, we can apply this framework to understand cell types involved in many different diseases," says study co-senior author Ferhat Ay, Ph.D., the Institute Leadership assistant professor of computational biology at LJI and an assistant adjunct professor at the UC San Diego School of Medicine.

The work, published Dec. 21, 2020, is part of LJI's DICE Cis-Regulatory Interactome Project.

DNA's Hidden Players

Many of us are taught that a cell has machinery that hums along the genetic code, "reading" genes and making proteins. But there are two key genetic players with hidden roles in this process.

First are "promoters." These are the DNA sequences that sit in the genetic code in front of genes. For a gene to be noticed, it needs to have a promoter. In 2018, the Vijayanand Laboratory published a seminal Cell study that revealed the impact of genetic variants in a set of human immune cells. This work gave Vijayanand's team a window into which genetic variants are important in which immune cells.

For the new study, Chandra and LJI Bioinformatics Postdoctoral Fellow Sourya Bhattacharyya, Ph.D., worked together to map the target genes for important DNA sequences called "enhancers." An enhancer serves as a specific switch to turn a gene on in a cell-specific manner.

"People have found a lot of these switches, but it hasn't been easy to know which switch is connected to which gene," Vijayanand says.

The researchers compare the situation to moving into a new house where you don't know which light switch controls which light--but on a much bigger scale. There could be a million switches, and the lights they control could be a mile away.

"We really want to figure out the wiring," says Ay.

Building a 3D Genetic Map

The scientists used a genome-wide mapping technique to finally see the wiring between the lights and switches. They knew that no matter how far away an enhancer was in the DNA code, it would need to find a way to be physically near the promoter it controls. The team's new 3D maps showed how enhancers on one part of a DNA strand actually loop around to meet promoters.

To their surprise, the researchers linked genes to enhancers very far away in the DNA sequences. Thinking at a molecular scale, for some of the genes, the enhancers appear miles away. "To date, fewer than a handful examples of such ultra-long distance connections have been discovered and validated" says Dr. Chandra, who performed genome editing experiments (CRISPR) that validated some of the discoveries in the paper.

Of course, the enhancer sequences are also made up of DNA letters. The new study shows that variations in the enhancer sequences can actually disable the "switch"--or impair the "wiring"--leading to problems in turning on the right gene in the right cell type. With their new maps, researchers can predict whether DNA sequence changes in these switches will increase disease risk in a person.

As with everything in genetics, even the promoters are more complex than scientists had realized. The new work shows that some "turned off" promoter sequences--previously thought to do nothing--are actually switching on genes far away in the DNA sequence. "They might be connected to other genes that you would never expect," says Ay.

This discovery means that researchers may need to change how they think of gene regulation. When researchers uncover a genetic variant linked to a disease, they usually go looking for the nearby gene. Now, they'll need to use different tools to hunt for potential target genes scattered through the genome.

"People working on all kinds of diseases are completely rethinking how they find variants and the genes they associate with," says Ferhat.

The LJI team will be helping though. Their findings in immune cells will be openly available online through the DICE (Database of Immune Cell Expression, Expression of quantitative trait loci and Epigenomics) database.

The new study also shows how this same approach can be used on other cell types. "The next steps are endless," says Vijayanand.

Credit: 
La Jolla Institute for Immunology

Enhanced scorpion venom molecules can be used to treat Chagas disease

Animal toxins are research targets owing to their therapeutic and biotechnological potential. Researchers at the Federal University of the ABC (UFABC), Federal University of São Paulo (UNIFESP) and Federal University of Ceará (UFC) in Brazil have discovered that VmCT1, an antimicrobial peptide isolated from the venom of the scorpion Vaejovis mexicanus, and its analogs kill Trypanosoma cruzi, the parasite that causes Chagas disease. Previous research has demonstrated VmCT1's potential against Gram-positive and Gram-negative bacteria, as well as tumor cells and other protozoans.

"VmCT1 contains 13 amino acid residues and displayed good selectivity and high potency against all three developmental phases of the protozoan Trypanosoma cruzi, the etiological agent of Chagas disease," said Vani Xavier de Oliveira Junior, a professor at UFABC's Center for Natural and Human Sciences and principal investigator for the study.

An article on the study is published in Parasitology, a journal owned by Cambridge University Press, and highlighted in the Cambridge Core Blog's Paper of the Month column. The study was supported by FAPESP.

"Not all species of scorpion are dangerous to humans," Oliveira said. "Venom from the genus Vaejovis affects only insects. On the other hand, it has potential therapeutic value because it contains several effective antimicrobial peptides, whose main role is defending the host."

Chagas is considered a neglected disease by the World Health Organization (WHO). It is endemic in several countries, affecting some 8 million people worldwide and killing around 10,000 per year.

"Treatment is currently available only in the form of two drugs that have severe side-effects and work only in the acute phase, when the patient may have few or no symptoms of the disease," Oliveira said. "This is why the search for novel medications is so important. Antimicrobial peptides are especially promising."

The researchers assessed the trypanocidal effect of VmCT1 and synthesized novel analogs with arginine substitutions in key positions to boost their biological action. Arginine is a positively charged amino acid and helps disrupt the parasite's membrane.

The results showed that the natural peptide was effective against all three phases of the parasite's development, while one of the analogs displayed both enhanced biological activity and better selectivity.

"In addition, we discovered that changes to physicochemical parameters influenced activity in the biological model, demonstrating that this kind of peptide reengineering can deliver more effective analogs than the native peptide," Oliveira said.

The selectivity of antimicrobial peptides to the pathogen relates to their cationicity, a trait that influences peptide-membrane interaction. According to the authors, the analogs with the positively charged amino acid arginine are more likely to interact with phospholipids in the membranes of microorganisms, promoting destabilization, disruption and/or permeabilization of the membranes.

"VmCT1 comprises a small peptide sequence, which helps obtain chemically altered molecules quickly and facilitates modulation between its biological activity and toxicity in human cells," said Cibele Nicolaski Pedron, a researcher at UFABC and first author of the article.

The trypanocidal activity was due to the formation of pores, evidenced by electron scanning microscopy. The damage done to the membranes by the peptides was significant, causing the death of parasites at levels not toxic to host cells.

"Our results demonstrate that VmCT1 and its arginine-substituted analogs are promising antiparasitic molecules that offer new prospects for the treatment of Chagas disease," said Alice Martins, a researcher at UFC and a co-author of the article.

The technological products developed in the study were registered with the National Industrial Property Institute (INPI), Brazil's patent and trademark office.

Credit: 
Fundação de Amparo à Pesquisa do Estado de São Paulo

Digging deep for differences in Duchenne muscular dystrophy

image: A UT Southwestern research team has catalogued gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchene muscular dystrophy (DMD) in humans. The findings, published online recently in PNAS, could lead to new treatments for this devastating degenerative disease and insights into factors that affect muscle development.

Image: 
UT Southwestern Medical Center

DALLAS - Dec. 21, 2020 - A UT Southwestern research team has catalogued gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchenne muscular dystrophy (DMD) in humans. The findings, published online recently in PNAS, could lead to new treatments for this devastating degenerative disease and insights into factors that affect muscle development.

Understanding the activity of genes can shed light on pathologies that affect different tissues in the body. However, says Rhonda Bassel-Duby, Ph.D., a professor of molecular biology at UTSW, studying skeletal muscle has been a challenge because of a key difference from other tissue types; rather than containing a single nucleus that controls the activity of the genes, a skeletal muscle fiber can contain hundreds of nuclei. And it was unknown which genes were activated in all these nuclei, making it unclear how gene expression differs between healthy skeletal muscle tissue and tissue affected by DMD.

To answer these questions, Eric Olson, Ph.D., chairman and professor of molecular biology at UTSW, Bassel-Duby, and their colleagues isolated tissue from the tibialis anterior, a muscle in mice similar to one in humans that runs down the shin. They took these samples from both healthy animals and from a mouse model of DMD that they generated using gene-editing technology to introduce a mutation that commonly causes DMD in people. The researchers then isolated muscle tissue from both sets of animals, In muscle fibers from both groups, the scientists identified 14 types of nuclei based on similar gene profiles. These nuclei appear to perform different jobs based on their predominant gene activity, such as maintaining mature muscle, liaising with neurons or tendons, or regenerating new muscle fibers. The researchers also identified nuclei of other types of cells, such as smooth muscle cells, endothelial cells, cells that produce fat or connective tissue, and immune cells known as macrophages.

When the researchers compared populations of these 14 different nuclei between the healthy and DMD mice, they found marked differences. For example, compared with the healthy animals, those with DMD had significantly fewer mature muscle nuclei. Instead, they had significantly more macrophages, reflecting the inflammation present in DMD muscles, as well as a category of regenerative cells not present in healthy tissue at all. Nuclei involved in interfacing with nerve cells and tendons had the most differences in gene expression between the two groups, suggesting that they're the most affected by DMD of all the nuclei types.

In addition, almost all the muscle nuclei isolated from the DMD animals had increased gene activity in the ubiquitin pathway, which tags proteins for degradation, as well as higher activation of genes that function in apoptosis, or cell death - reflecting the degradation of muscle that characterizes DMD.

Bassel-Duby notes that the study has a couple of key limitations: For example, the technology used did not reveal where the muscle nuclei were located within the muscle tissue, which could lend valuable clues on how nuclei might communicate with each other and affect gene activity. It's also still unknown if mending the genetic mutation that causes DMD might return gene activation to normal. She and her colleagues plan to investigate both these questions in future studies.

By developing a better understanding of how muscle fibers operate in both healthy and diseased tissue, she adds, researchers could eventually learn to manipulate gene activity to optimum levels. As a more immediate goal, identifying differences present in DMD patients could lead to new targets for treatment.

"Identifying specific gene activities in these nuclei could give us new ideas for treatments that have been previously overlooked," Bassel-Duby says. "Ultimately, we could eventually find ways to prevent these patients' muscles from degenerating and improve their quality of life."

"Our study provides new insights into the molecular underpinnings of Duchenne muscular dystrophy at an unprecedented level of resolution and highlights a collection of genes and signaling pathways with central roles in this disease," adds Olson. "This work opens the door to new approaches for ameliorating the severe pathological consequences of this disease through either pharmacological or genetic interventions."

Credit: 
UT Southwestern Medical Center

What if clean air benefits during COVID-19 shutdown continued post-pandemic?

A new study by Columbia University Mailman School of Public Health researchers poses a hypothetical question: What if air quality improvements in New York City during the spring 2020 COVID-19 shutdown were sustained for five years without the economic and health costs of the pandemic? They estimate cumulative benefits of clean air during this period would amount to thousands of avoided cases of illness and death in children and adults, as well as associated economic benefits between $32 to $77 billion. The study's findings are published in the journal Environmental Research.

The researchers leveraged the unintended "natural experiment" of cleaner air in New York City during the COVID-19 shutdown to simulate the potential future health and economic benefits from sustained air quality improvements of a similar magnitude. They do not frame this study as an estimate of the benefits of the pandemic. Rather they offer this hypothetical clean air scenario as an aspirational goal for policies to reduce emissions, largely from fossil fuel combustion.

Exploratory analyses found that neighborhoods with higher percentages of low-income residents or higher percentages of Black or Latinx residents tended to have proportionally higher benefits from reduced PM2.5 concentrations when compared to neighborhoods with lower levels of poverty or Black or Latinx populations. However, this does not mean that the disparity in health outcomes across neighborhoods would be eliminated under this scenario because underlying risk factors would still remain. The researchers also caution that limited air quality monitors and available data during the shutdown period constrained their ability to assess the impact of improved air quality on health disparities across neighborhoods.

Air quality improvements during the New York City spring shutdown were the result of an estimated 60-percent decline in automobile traffic, as well as declines in air traffic, construction, restaurant operation, and electricity generation.

"Air quality improvements from the shutdown happened as the result of a tragic situation. However, our hypothetical clean air scenario could be achieved through air pollution and climate mitigation policies, including those that support low carbon modes of transportation and reduce emissions in other sectors," says study first author Frederica Perera, DrPH, PhD, director of translational research at the Columbia Center for Children's Environmental Health and professor of environmental health sciences at Columbia Mailman School.

The researchers estimated a citywide 23-percent reduction in fine particulate matter (PM2.5 ) concentrations during the COVID-19 shutdown period (March 15-May 15, 2020) compared to the average level for those months in 2015-2018 (the business-as-usual period) using air quality monitoring data from the New York State Department of Environmental Conservation. Based on 2020 data, they extrapolated ambient levels of PM2.5 for a five-year period. They then used BenMAP, a publicly available computer tool supported by the U.S. Environmental Protection Agency, to estimate the number of avoided air pollution-related illnesses and deaths and quantify their economic value using methods the researchers developed in earlier research. Specifically, they estimate potential avoided cases of infant and adult mortality, adverse birth outcomes, autism spectrum disorder, and childhood asthma.

Credit: 
Columbia University's Mailman School of Public Health

New research shows masks change the way we process faces

image: Examples of faces with and without masks similar to the ones used in the experiment. Faces are reproduced with permission from the Chicago Face Database

Image: 
The Chicago face database: A free stimulus set of faces and norming data.

Feel like you're suffering from face blindness? Research shows masks change the way we process faces

TORONTO, Dec. 21, 2020 - Ever want to walk over to say hello to someone but you're not sure the person behind the mask is in fact someone you know? Researchers at York University in Toronto and Ben-Gurion University in Israel say you're not alone. A new study, led by researchers in the Faculty of Health and VISTA (Vision Science to Applications) program at York, finds that our ability to recognize faces is severely impaired by masks, and this decreased face perception is impacting our social interactions with others.

"Face masks are an essential tool in our efforts to minimize COVID-19 transmission, and those masks are here for the foreseeable future. Therefore, it is important to understand how masks affect our most important perceptual ability, that is face perception," says Professor Erez Freud, of the Department of Psychology at York University's Faculty of Health. "We found not only that face masks reduce our ability to recognize faces, but also that they change the way we process faces. Face perception typically relies on holistic processing, that is the processing of the face as whole. However, for masked faces, this form of perception is not as efficient, and observers process different face features separately."

Freud and his co-authors recruited 496 adults to complete a common face recognition task online in which they viewed unfamiliar faces and then tried to recognize them under different conditions. The sample included 253 females and 243 males.

Using an adapted version of the Cambridge Face Memory Test ? the most validated measure of face perception abilities in humans ? they evaluated face processing abilities for masked and unmasked faces. Participants in the study were randomly assigned to one of two groups.

The researchers found that masks interfere with what is considered as normal, holistic processing of faces. This decrease in performance moves a substantial number of participants into the lower performance range often found in people with a congenital deficit in face perception (known as "face blindness" or prosopagnosia).

"The face inversion effect is a well-known phenomenon that shows a reduced ability to identify inverted faces compared to upright faces," says Freud. "During our experiment, we found that this well-known inversion effect is reduced for masked faces, suggesting that those faces are processed in a more analytical manner, by specific features rather than the greater whole. This finding can explain why it is so difficult for us to perceive masked faces. If we can't create a holistic representation of a masked face, then our face recognition ability is more likely to fail."

We use face recognition in every aspect of our social interaction; we find clues for the identity, gender, emotion, and intentions of people around us, say researchers. However, in the era of face masks, faces do not look the same. This change is what researchers say may impact our ability to interact with people around us and interpret social interaction.

These changes in performance could have significant effects on activities of daily living as well as other situations involving personal interactions, such as education. Given that mask wearing has rapidly become an important norm in countries around the globe, future research should explore the social and psychological implications of wearing masks on human behaviour, the researchers say.

The study, published in Scientific Reports today was led by Freud in collaboration with Professor Shayna Rosenbaum, both of the Department of Psychology and the Centre for Vision Research at York University, and Andreja Stajduhar, an undergraduate student in the Department of Psychology, and was co-authored by Professors Tzvi Ganel and Galia Avidan in the Department of Psychology at Israel's Ben-Gurion University.

Credit: 
York University

High-five or thumbs-up? New device detects which hand gesture you want to make

image: UC Berkeley researchers have created a new device that combines wearable biosensors with artificial intelligence software to help recognize what hand gesture a person intends to make based on electrical signal patterns in the forearm. The device paves the way for better prosthetic control and seamless interaction with electronic devices.

Image: 
Image courtesy the Rabaey Lab

Berkeley -- Imagine typing on a computer without a keyboard, playing a video game without a controller or driving a car without a wheel.

That's one of the goals of a new device developed by engineers at the University of California, Berkeley, that can recognize hand gestures based on electrical signals detected in the forearm. The system, which couples wearable biosensors with artificial intelligence (AI), could one day be used to control prosthetics or to interact with almost any type of electronic device.

"Prosthetics are one important application of this technology, but besides that, it also offers a very intuitive way of communicating with computers." said Ali Moin, who helped design the device as a doctoral student in UC Berkeley's Department of Electrical Engineering and Computer Sciences. "Reading hand gestures is one way of improving human-computer interaction. And, while there are other ways of doing that, by, for instance, using cameras and computer vision, this is a good solution that also maintains an individual's privacy."

Moin is co-first author of a new paper describing the device, which appeared online Dec. 21 in the journal Nature Electronics.

To create the hand gesture recognition system, the team collaborated with Ana Arias, a professor of electrical engineering at UC Berkeley, to design a flexible armband that can read the electrical signals at 64 different points on the forearm. The electrical signals are then fed into an electrical chip, which is programmed with an AI algorithm capable of associating these signal patterns in the forearm with specific hand gestures.

The team succeeded in teaching the algorithm to recognize 21 individual hand gestures, including a thumbs-up, a fist, a flat hand, holding up individual fingers and counting numbers.

"When you want your hand muscles to contract, your brain sends electrical signals through neurons in your neck and shoulders to muscle fibers in your arms and hands," Moin said. "Essentially, what the electrodes in the cuff are sensing is this electrical field. It's not that precise, in the sense that we can't pinpoint which exact fibers were triggered, but with the high density of electrodes, it can still learn to recognize certain patterns."

Like other AI software, the algorithm has to first "learn" how electrical signals in the arm correspond with individual hand gestures. To do this, each user has to wear the cuff while making the hand gestures one by one.

However, the new device uses a type of advanced AI called a hyperdimensional computing algorithm, which is capable of updating itself with new information.

For instance, if the electrical signals associated with a specific hand gesture change because a user's arm gets sweaty, or they raise their arm above their head, the algorithm can incorporate this new information into its model.

"In gesture recognition, your signals are going to change over time, and that can affect the performance of your model," Moin said. "We were able to greatly improve the classification accuracy by updating the model on the device."

Another advantage of the new device is that all of the computing occurs locally on the chip: No personal data are transmitted to a nearby computer or device. Not only does this speed up the computing time, but it also ensures that personal biological data remain private.

"When Amazon or Apple creates their algorithms, they run a bunch of software in the cloud that creates the model, and then the model gets downloaded onto your device," said Jan Rabaey, the Donald O. Pedersen Distinguished Professor of Electrical Engineering at UC Berkeley and senior author of the paper. "The problem is that then you're stuck with that particular model. In our approach, we implemented a process where the learning is done on the device itself. And it is extremely quick: You only have to do it one time, and it starts doing the job. But if you do it more times, it can get better. So, it is continuously learning, which is how humans do it."

While the device is not ready to be a commercial product yet, Rabaey said that it could likely get there with a few tweaks.

"Most of these technologies already exist elsewhere, but what's unique about this device is that it integrates the biosensing, signal processing and interpretation, and artificial intelligence into one system that is relatively small and flexible and has a low power budget," Rabaey said.

Credit: 
University of California - Berkeley

How to be happier in 2021

So you want to look trimmer, be smarter, and successful next year? You strive to exercise and call your friends more, and spend less?

You are not alone. New Year's resolutions are as ubiquitous as they are difficult to keep. Does it even make sense to set such lofty goals for the new year, hoping anew each January first that this time really is the charm?

Any motivational researcher would have "ambivalent feelings" about New Year's resolutions, says Richard Ryan, an international expert on motivational research and professor emeritus of psychology at the University of Rochester. "The evidence shows that most of the time people aren't successful at them."

But don't throw in the towel quite yet. Ryan, who is also a clinical psychologist, says that any occasion that gives us an opportunity to reflect on our lives is ultimately a good thing. It doesn't have to be on New Year's. "Whenever that happens, if it's really a reflective change--something that you put your heart behind--that can be good for people."

And he has another tip: what proves most satisfying, and may also be what's most needed as the COVID-19 pandemic rages on, are goals that involve giving to others.

"Think of how you can help," says Ryan. "There's a lot of distress out there: If we can set goals that aim to help others, those kinds of goals will, in turn, also add to our own well-being."

His advice is grounded in decades of research. Together with Edward Deci (also a University of Rochester professor emeritus of psychology) Ryan is the cofounder of self-determination theory (SDT), a broad framework for the study of human motivation and personality. Developed by the duo over nearly 40 years, the theory has become one of the most widely accepted frameworks of human motivation in contemporary behavioral science. Its starting point is the idea that all humans have the natural--or intrinsic--tendency to behave in effective and healthful ways.

According to Ryan, who is also a professor at the Institute for Positive Psychology and Education at Australian Catholic University, acts of willingly helping others satisfy all three of the basic psychological needs identified in SDT research: the needs for autonomy, competence, and relatedness. Autonomy in this context means that you can engage in activities in which you feel true volition and find personal value. Competence means feeling effective and having a sense of accomplishment. Finally, relatedness means working with and feeling connected to others.

"If you want to make a New Year's resolution that really makes you happy, think about the ways in which you can contribute to the world," says Ryan. "All three of these basic needs are fulfilled. The research shows it's not just good for the world but also really good for you."

Q&A: Why New Year's resolutions (often) don't work

What's the problem with most New Year's resolutions?

The saddest part is that most people don't succeed at their January 1 resolutions. But that is because most of these midnight resolutions look more like pressure coming from the outside--an attempt to look better, relieve guilt, or meet the standards of others. Losing weight, for example, is one of the most common New Year's goals and one that people tend to do poorly at. Part of the reason for that is where it's coming from: it's often coming from internal or external pressure--as opposed to a goal that's something that you might intrinsically value such as having more health or vitality. If the goal is one that is not "authentic" and not really coming from your own values or interests, the energy for it fades fast.

Are any resolutions particularly toxic?

There are many goals that even when achieved will not bring people more happiness. A goal of making more money, for example, may get a person working harder, but may actually leave them less connected to others, or feeling less autonomy on a day-to-day basis. It could make the person less happy. Goals that work are ones where we can find real satisfaction in achieving them.

It's intuitive that giving to others is satisfying. But how does that work on a psychological level?

We found that when people are focused on giving to others they experience deeper satisfactions than when their goals are more self-oriented. For example, experiments show that doing something benevolent for others, even when you will never meet the beneficiary, increases your positive mood and energy. Most recently, we published a study [in the Journal of Personality and Social Psychology] about what we call people's "integrative span." We discovered that your happiness increases as your focus of concern and care gets wider. If your main concerns and cares are narrow and selfish--just about "me and the people very close to me," versus about "my family and my community," versus about "the larger world and everything in it"-- the less happy you are prone to be. A broader scope of caring and concern for others, in contrast, predicts a higher well-being.

How do we make any resolution more likely to stick?

Beyond the focus of your goals, there are some key elements to success at any resolution you might make. First, make sure your goal is one you truly embrace--that you are fully behind and care about. An achievable goal is also one that is not abstract, like "improve my health" but concrete--such as "increase my daily step count" or "drink sparkling water rather than sugared soda at lunch." These latter goals are clear and achievable in a way that a vague global resolution can never be. Once having a clear aim, the next step is making a realistic plan on how and when it will be implemented.

Just as important, research shows that the more you can make achieving your resolution fun and "intrinsically motivated" the more you'll persist. For example, a plan to increase your step count might include a walk each day with a good friend--which will both achieve your step goal and satisfy relatedness needs. By finding an activity that both gets you to your goal and that you actually enjoy--or at least don't find aversive--you'll be more likely to carry on.

Finally, successful resolutions are usually built upon optimal challenges. Setting the bar too high will feel discouraging and lead to disengagement. Keep in mind that with almost any long-term goal the best strategy is to set small incremental goals--not "I'm going to climb Everest" but rather "I'm going to take these first few steps toward base camp."

Any special advice for 2021?

The past year has been tough; you can make the new one kinder. Any new goals you set that involve changing habits or lifestyles will inevitably involve some setbacks, lapses, and failures. So when failures happen, remember to be a compassionate self-coach. Forget the harsh judgments and instead take interest in what you can learn from the setback and where you got stuck. And then restart with that much more wisdom in hand.

How do I find the goal I ultimately most care about?

For most of us, if we give ourselves occasional moments of reflection-taking the time to really think about what's going well in our lives and what really matters-we can usually identify some things we could change. Often that means listening to that little nagging feeling about the things that we know would improve our lives. It means allowing ourselves to tune into that inner signal in an open, non-defensive way and to consider the possibilities and the choices that you really have. In truth, there are always ways to make life better, but the road upward need not be a painful one--if you are going in the right direction.

Credit: 
University of Rochester

Study published on the well-being of small business workers during COVID-19

(AURORA, Colo.) December 21, 2020 - As the pandemic was starting to take hold, researchers from the Center for Health, Work & Environment (CHWE) at the Colorado School of Public Health (ColoradoSPH) performed a study to better understand the impact of COVID-19 on the well-being of workers in Colorado. The team evaluated changes to employees' work and home life resulting from COVID-19 and individual perceptions of workplace safety and health climates. These climates reflect employee perceptions of how committed their employer is to their safety and health. They are commonly used as an indicator of organizational safety and health cultures.

This study, published in the Journal of Occupational and Environmental Medicine, examined whether safety and health climates were related to employee well-being during the COVID-19 pandemic in a sample of small businesses. CHWE has become an expert in the field of small business safety and health research based on its Small + Safe + Well (SSWell) study, a four-year, Total Worker Health® intervention. The research group distributed a COVID-specific employee survey to the existing employer group of SSWell organizations and received responses from 491 employees from 30 small businesses across Colorado.

"When the pandemic hit last spring, we knew that work changed significantly. We wanted to understand how the small businesses in our SSWell study were responding to the pandemic and how this was related to their employees' health," said Dr. Natalie Schwatka, one of the lead researchers and assistant professor at the ColoradoSPH.

"We learned that when employees perceived strong health and safety climates, they also reported better well-being," says Dr. Carol Brown, lead researcher and deputy director of CHWE. Employee perceptions of safety and health climates were significantly, positively related to their self-reported well-being during the first wave of COVID-19, even when there were changes to childcare, the ability to work, and limited social contacts.

"Safety and health climates may influence employee well-being even when other disruptions occur, suggesting that during emergencies, small businesses with strong climates may be better prepared to maintain employee well-being," according to Dr. Schwatka.

The team hopes the results of the survey will encourage organizations to approach emergency preparedness as a health and safety issue. "Businesses cannot always predict when an emergency is going to happen, but they can create a working environment that supports their employees' health, safety, and well-being" says Dr. Schwatka. "In doing so, they have laid a foundation for how to successfully respond to an emergency."

Credit: 
University of Colorado Anschutz Medical Campus

Scientists uncover mechanisms that wire the brain's cerebral cortex

image: Michael Fox, a professor at the Fralin Biomedical Research Institute at VTC and director of the School of Neuroscience in Virginia Tech's College of Science, led a study that may help reveal the molecular underpinnings of seizures and psychiatric disorders.

Image: 
Virginia Tech

A research team led by Michael Fox, a professor at the Fralin Biomedical Research Institute at VTC, has identified the type of brain cell that produces collagen 19, a protein that is crucial for the formation of inhibitory circuits in the brain.

The study, published in the Journal of Neuroscience, depicts a previously unknown molecular mechanism underlying healthy brain development.

Neurons and glia are the most abundant types of brain cells. Glia, in particular star-shaped glia called astrocytes, release signaling molecules that support the growth and maintenance of healthy synapses, the chemical communication structures between neurons.

Yet in this study, Fox's team discovered that a type of interneuron, a cell type that interprets and relays information sent from other neurons, produces the majority of brain-derived collagen 19 to stimulate synapse formation.

"At a time when many studies are identifying interneuron-like roles for astrocytes, we've identified an unexpected astrocyte-like role for interneurons," said Fox, who is also the director of the School of Neuroscience in Virginia Tech's College of Science.

In previous research, Fox’s team discovered that mice lacking the gene that encodes collagen 19 exhibit a loss of inhibitory synapses surrounding neuronal cell bodies located in the brain's hippocampus and neocortex. In humans, these brain regions are involved in cognitive functions, such as reasoning, language, perception, memory, and learning. They have also been shown to play roles in sensory perception, memory, and learning in mice.

Excessive excitatory connections between neurons in these brain areas could explain why mice with this genetic mutation are more prone to develop seizures and behavioral abnormalities. This gene has also been associated with neuropsychiatric disorders in humans. In particular, it's been suggested that loss of this gene in humans could be associated with familial cases of schizophrenia, a brain disorder that afflicts more than 2 million Americans, according to the National Institute of Mental Health.

But Fox's earlier discovery about the importance of collagen 19 beckoned another question: Where does this protein come from?

In the new study, the scientists used riboprobes - small segments of ribonucleic acids (RNA) that bind to complementary segments of RNA - to look for different cell type markers in normal mice, wild-type, and mice with the genetic mutation. This method revealed that the majority of brain-derived collagen 19 is produced by a type of interneuron.

This interneuron type is one of the first to develop in the neocortex and it plays a role in helping surrounding synaptic circuits mature. In this case, after this type of interneuron releases collagen 19 molecules, the proteins serve as a signal that instructs another abundant type of interneuron to produce inhibitory synapses.

"Initially when we proposed this, some people thought it was far-fetched that one neuron could influence another cell's development when they're not synaptically coupled," Fox said.

Roughly 20 percent of a person's body mass is made of collagens, which form the matrix of connective tissue that wraps around organs, muscles, and cellular structures. Because of the complex molecular structure of collagens, just a small genetic variation alters the protein's shape, rendering the collagen molecule useless waste that cells destroy and recycle for parts.

Collagen genetic mutations are linked to a litany of connective tissue disorders, but Fox says they're still underexplored in the brain.

"What keeps me interested in this project is that we know so little about the role that extracellular matrix proteins like collagen 19 play in mediating healthy circuit formation," Fox said. "When you're a student taking a neuroscience class, you'll often learn that the brain doesn't have a lot of connective tissue in it, but we're finding more and more that the presence of these extracellular matrix proteins actually seems to lay the foundation for healthy brain development."

Fox's lab plans to build on this discovery by working to develop new ways to restimulate inhibitory synapse growth in diseased or injured brains. The team previously found that a small peptide derived from this collagen, matricyptin, is sufficient to promote the growth of inhibitory synapses in cells lacking collagen 19.

"We want to translate what we're learning about how these circuits develop into therapeutics," Fox said. "We've found a peptide that shows some promise in stimulating inhibitory synapse formation and are studying ways to employ it."

Credit: 
Virginia Tech

New method for imaging exhaled breath could provide insights into COVID-19 transmission

video: The new imaging technique was used to image a professional musician playing a flute. The video shows that a commercially available attachment can effectively redirect air flow from the flute. This is a demonstration of the published imaging technique that is being further investigated. The imaging shows only the temperature change associated with exhaled breath, which does not necessarily reflect the movement of viral particles contained in the breath.

Image: 
Thomas Moore, Rollins College

WASHINGTON -- A new method for visualizing breath that is exhaled while someone is speaking or singing could provide important new insights into how diseases such as COVID-19 spread and the effectiveness of face masks.

"Scientists believe the SARS-CoV-2 virus is primarily spread through respiratory droplets that can be carried in the breath or expelled through coughing or sneezing," said Thomas Moore from Rollins College, who performed the research. "But it is also transmitted by airborne aerosols, which are small particles that remain in the air longer than the larger droplets. The system I developed provides a way to estimate how far the breath travels before being dispersed into the surrounding air and can provide visual evidence that masks significantly limit the distance the breath travels in the air."

In The Optical Society (OSA) journal Applied Optics, Moore describes how he used a variation of electronic speckle pattern interferometry to image temperature differences between exhaled breath and the surrounding air. The new technique can also be used to study the details of how breath flows from the mouth while speaking or singing, which could be useful for music instruction and speech therapy.

From musical instruments to people

Moore originally developed the imaging technology to study the flow of air through musical instruments such as organ pipes. "In response to the COVID-19 pandemic, I began imaging the breath of people speaking and singing," he said. "I realized that by scaling up my existing system, I could likely determine how far the breath extends and how effective masks may be in limiting the extent of the breath."

Most existing approaches used to image exhaled breath require expensive equipment and can image only a relatively small area. Moore designed a system that uses common commercially available optical components to overcome these limitations.

"I used a variation of electronic speckle pattern interferometry, which has been used for many years to study the vibrational patterns of solid objects," said Moore. "The innovation was to change the system in such a way that it can be used to image transparent things, such as the breath, instead of solid vibrating objects."

The imaging system uses the fact that the speed of light will change depending on the temperature of air it passes through. Because the breath is warmer than the surrounding air, the light transmitted through the breath arrives at the camera slightly sooner than light that did not pass through it. This slight difference in the speed of light can be used to create images of exhaled breath.

Moore tested the new system by imaging the breath of two professional vocalists singing and a professional musician playing a flute, one of the few instruments where the musician blows directly into the surrounding air. "The work with the musicians immediately confirmed that the system worked well and could be used to study a variety of problems," he said.

Changing the air flow

Moore is currently using the method to study how effective masks are at reducing the distance that exhaled aerosols travel. He is especially interested studying singing because research indicates that more aerosol is exhaled while singing or speaking loudly than when speaking normally. He is also working to make the system more stable against vibrations and to further increase the size of the system to image larger areas.

Moore says that the technique has already revealed new information that may affect how we approach distancing and masking requirements, especially when outdoors. He expects to submit these results for publication soon.

"The pandemic has caused an economic catastrophe for many musicians, and any information we can give them that will help them get back to work is important," said Moore. "We have had a lot of interest from the musical community, and I expect the healthcare community will also be interested once we begin to publish our results."

Credit: 
Optica

Female athletes in WNBA don't return to elite performance for at least 2 years after ACL surgery

image: Dr. Okoroha is the study's senior author.

Image: 
Henry Ford Health System

DETROIT (December 21, 2020) - With the Michigan high school and collegiate sports season influx due to the COVID-19 pandemic, a study by Sports Medicine researchers at Henry Ford Health System provides a new perspective on performance levels of female professional athletes after they return from anterior cruciate ligament (ACL) injury and reconstructive surgery.

The study published in the Orthopaedic Journal of Sports Medicine found that players in the Women's National Basketball Association didn't regain their elite performance level for at least two years after injury. That's about a year longer than players in the National Basketball Association who suffered the same injury. Additionally, WNBA players had significantly lower performance numbers in games played, games started, minutes played, points scored, rebounds, assists and blocked shots during the season in which they returned to play.

The Henry Ford Sports Medicine research team that included Lafi Khalil, M.D., and lead author Joseph Tramer, M.D., noted that the findings are important for both players and coaches to set reasonable expectations for returning , not only at the professional level but also at collegiate and high school levels.. Numerous studies have identified many causes that contribute to high rates of ACL injuries in female athletes including differences in lower extremity muscle activation, joint laxity, neuromuscular control, knee anatomy and hormonal factors.

"The data on WNBA players' ACL tears and reconstruction has been previously studied, but what previous investigations did not evaluate is the performance levels after returning from these injuries," said Kelechi Okoroha, M.D., the study's senior author. "The players we studied were back playing after seven months, but the statistical data revealed that they didn't return to their previous performance numbers on the court until their second or third year back on the court."

Orthopedic studies confirm that female athletes are 2 to 10 times more likely to sustain an ACL tear than male athletes, depending on the sport. With basketball players, females are at 2 to 7 times greater risk.

The ACL is an important ligament in stabilizing the knee and many professional athletes' season have come to a sudden end thanks to this very common injury. In the U.S., approximately between 100,00 and 200,000 ACL ruptures occur annually. ACL reconstructions are among the most common sports medicine procedures performed, numbering about 100,000 each year.

In this retrospective study, researchers evaluated ACL injuries in 59 WNBA players from 1997-2018 and their impact on their return to sport and performance level. Data was collected for each player before and after injury to assess changes in playing time and statistical performance. Players who returned to play after ACL reconstruction were compared with their uninjured counterparts.

Key performance findings on average in the first year after surgery:

Games played decreased from 69.6 to 57

Minutes played decreased from 23.4 to 18.4

Points per game decreased from 10.2 to 6.5

Dr. Okoroha has led similar respective performance studies of NBA, NFL and MLB male athletes and thinks this research of female athletes is important in comparing the information and accurately counseling athletes returning from ACL injury.

"In comparison, the WNBA players returned to competition at a lower rate (69.5%) than NBA players with similar injuries (88.9%) and their performance numbers were measuredly lower once they returned," said Dr. Okoroha.

As a former college basketball player and team captain at Xavier University of Louisiana, Dr. Okoroha also brings a player's perspective on the implications of ACL injuries, "Some of my teammates suffered ACL ruptures. These are devastating injuries that not only impact a player's morale and outlook but also require a great deal of mental and physical work to return to previous performance levels," said Dr. Okoroha.

Credit: 
Henry Ford Health

Reston ebolavirus spreads efficiently in pigs

image: This colorized transmission electron micrograph shows a slice of Reston virus particles (blue) in the lung of an infected pig.

Image: 
NIAID

WHAT:

Reston ebolavirus (RESTV) should be considered a livestock pathogen with potential to affect other mammals, including people, according to National Institutes of Health scientists. The caution comes from a study published in Proceedings of the National Academy of Sciences in which the scientists found that experimental piglets infected with RESTV developed severe respiratory disease and shed the virus from the upper respiratory tract. RESTV can infect humans but is not known to cause disease. Now the scientists express concern that pigs could serve as an "interim or amplifying host for ebolaviruses."

"The emergence of RESTV in pigs is a wake-up call as transmission into humans through direct contact with pigs or the food chain is a possibility," they state in their study report. Scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) conducted the work at Rocky Mountain Laboratories in Hamilton, Montana.

Scientists first identified RESTV in 1989 in research monkeys shipped from the Philippines to Reston, Virginia. The virus also gained attention in 2008 when an outbreak swept through pigs in the Philippines. That outbreak led to the first association of pig-to-human RESTV transmission, prompting the World Health Organization to issue a global alert in February 2009. RESTV sequences also have been identified in pigs in China, and the scientists suggest officials monitor pigs for disease throughout the Philippines and Southeast Asia.

The NIAID scientists conducted their study to answer two key questions: could they cause disease in young pigs--mimicking natural infection with RESTV isolated from the 2008 swine outbreak--and if so, would those pigs shed virus through their respiratory tract? Their work confirmed that in fact the pigs developed severe pneumonia with virus shedding from the upper respiratory tract. They also determined that the age of the piglets at the time of infection--they used animals between three and seven weeks old--did not change the course of disease. Their work involved Yorkshire cross-bred pigs, which frequently are used in commercial pig production systems. RESTV has not been found in commercial pigs in the United States.

Continued studies in this project will examine whether co-infection with other swine viruses affects the ability of RESTV to cause severe disease in pigs and whether pigs have a broad role in hosting ebolaviruses.

Credit: 
NIH/National Institute of Allergy and Infectious Diseases

Child care facilities can be safe and are essential: new Case Western Reserve study

Cleveland - Child care programs can be safe within the context of low community transmission of COVID-19, according to new research from Case Western Reserve University, based on data from child care programs throughout Ohio.

The study took place from Aug. 15 to Nov. 20, during a timeframe of relatively low community transmission of COVID-19. The team found COVID-19 infection rates at child care programs have been low as a result of:

clear and comprehensive state guidelines for mitigating transmission within child care settings;

streamlined reporting of cases to monitor trends;

resources to support adherence to state guidelines; and

high compliance with these guidelines by child care workers and families.

The Case Western Reserve study was funded by the Ohio Bureau of Workers' Compensation (BWC) and supported by the Ohio Department of Job and Family Services (ODJFS). The study relied on a sample of child care facilities that mirrors a mix of urban, suburban, and rural settings found across the country, offering insight into child care experiences nationally.

Additional findings from the ongoing study will provide another look as community transmission rates rise, with data collection continuing until the end of December. These new findings will be released in early 2021.

"We all have seen reports from across the country of vast numbers of parents--mostly women--dropping out of the workforce during the pandemic to care for their children as schools and child care facilities closed," said Darcy Freedman, professor of Population and Quantitative Health Sciences at the Case Western Reserve School of Medicine and director of the Mary Ann Swetland Center for Environmental Health, who served as the principal investigator of the study. "How to reopen and stay open safely is important to tens of thousands of families across the state and hundreds of thousands of families across the country."

The findings show that child care programs in Ohio may have had higher readiness to handle COVID-19 than other sectors of the economy because of already-existing standards designed to promote safe and healthy environments, Freedman said. These, combined with statewide infection control guidelines adopted with high compliance by child care workers and families, resulted in lower levels of COVID-19 transmission within child care settings during the study's initial phase through early November.

But Freedman cautioned that additional supports, such as steady access to affordable personal protective equipment (PPE) and sanitizing materials, may be needed for child care programs to remain vigilant as the COVID-19 epidemic continues.

Case Western Reserve researchers note that public health officials anticipate that even with the distribution of a vaccine, communities across the country may continue to see consistent low to moderate community transmission rates through 2021.

From the start of the pandemic in March 2020 until Nov. 13, less than 1% of all COVID-19 cases in Ohio were among child care workers and children affiliated with child care programs, based on incident reporting from child care programs to ODJFS. During most of the study's timeframe, COVID-19 positivity rates in Ohio were below the 5% threshold used to establish low risk of community transmission. COVID-19 positivity rates in Ohio began rising above 5% starting Oct. 20.

"Maintaining safety within child care programs requires capacity for staff and families to fully adhere to mitigation strategies, both within child care programs and outside in the community," Freedman said.

More than 6,000 child care programs are licensed in the state. Pre-pandemic, these facilities cared for more than 500,000 children each day. The Case Western Reserve survey of parents participating in this study noted that shuttering child care programs due to COVID-19 transmission would have the following results:

Nearly 75% of families would have to reduce their work hours.

More than half of families--59%--would need one person in the household to leave the workforce to stay home with children.

Key recommendations based on the study findings:

Maintain child care capacity to fully comply with COVID-19 mitigation strategies;

Develop a supply chain for affordable personal protective equipment and cleaning materials, allowing child care programs to uphold rigorous hygiene and sanitizing procedures;

Standardize communication about COVID-19 disseminated through child care programs;

Expand workforce pipeline for child care staffing during the pandemic.

Credit: 
Case Western Reserve University

Nobel Prize reflects perseverance in scientific research

image: Topics cover both human and animal viral immunology, exploring viral-based immunological diseases, pathogenic mechanisms, and virus-associated tumor and cancer immunology. The Journal includes original research papers, review articles, and commentaries covering the spectrum of laboratory and clinical research and exploring developments in vaccines and diagnostics targeting viral infections.

Image: 
Mary Ann Liebert, Inc., publishers

New Rochelle, NY, December 21, 2020--The 2020 Nobel Prize in Physiology or Medicine went to three researchers for their discovery of hepatitis C virus (HCV). The undying perseverance that it took to find and cure this elusive virus is eloquently detailed in the peer-reviewed journal Viral Immunology. Click here to read the article now.

Rodney S. Russell, PhD, Editor-in-Chief of Viral Immunology, from Memorial University of Newfoundland, St. John's, recounts his own research experience with HCV and tells the story of how the virus was discovered.

"The strongest theme I see in the field of HCV research is perseverance," says Dr. Russell. "Finding HCV was not easy, working with HCV was not easy, curing HCV was not easy, and even now, making an effective vaccine against HCV is proving not to be easy. What impresses me most about the thousands of scientists around the world who contributed to the study of this virus, even before it was discovered, was, and still is, their absolute unwillingness to quit."

Credit: 
Mary Ann Liebert, Inc./Genetic Engineering News

The far-reaching effects of mutagens on human health

image: Michael Lynch is the director of the Biodesign Center for Mechanisms of Evolution and professor at ASU's School of Life Sciences.

Image: 
The Biodesign Institute at Arizona State University

In order to survive, flourish and successfully reproduce, organisms rely on a high degree of genetic stability. Mutagenic agents, which can threaten the integrity of the genetic code by causing mutations in DNA, pose a serious risk to human health. They have long been implicated in a range of genetically inherited afflictions, as well as cancer, aging and neurodegenerative diseases like Alzheimer's.

It now appears that mutagenic threats to a cell's subtle machinery may be far more widespread than previously appreciated. In a new study, Michael Lynch and his colleagues demonstrate that DNA mutation itself may represent only a fraction the health-related havoc caused by mutagens.

The study highlights the ability of mutagenic compounds to also affect the process of transcription, during which a DNA sequence is converted (or transcribed) to mRNA, an intermediary stage preceding translation into protein.

The research findings, (which highlight mutagenic transcription errors in yeast, worms, flies and mice), suggest that the harmful effects of mutagens on transcription are likely much more pervasive than previously appreciated--a fact that may have momentous implications for human health.

"Our results have the potential to completely transform the way we think about the consequences of environmental mutagens," Lynch says.

Professor Lynch is the director of the Biodesign Center for Mechanisms in Evolution and a researcher in ASU's School of Life Sciences.

The research results appear in the current issue of the journal PNAS.

Cells under threat

Due to their important role in disease processes, mutagenic compounds have long been a topic of intensive scientific study. Such agents include sunlight and other sources of radiation, chemotherapeutics, toxic byproducts of cellular metabolism, or chemicals present in food and water.

Mutagens can inflict damage to the DNA, which can later snowball when cells divide, and DNA replication multiplies these errors. Such mutations, if not corrected through DNA proofreading mechanisms, can be passed to subsequent generations and depending on the location at which they appear along the human DNA strand's three billion letter code may seriously impact health, in some cases, with lethal results.

But even if repaired prior to replication, transiently damaged DNA can also interfere with transcription--the process of producing RNA from a DNA sequence. This can happen when RNA polymerase, an enzyme that moves along a single strand of DNA, producing a complementary RNA strand, reads a mutated sequence of DNA, causing an error in the resulting RNA transcript.

Because RNA transcripts are the templates for producing proteins, transcription errors can produce aberrant proteins harmful to health or terminate protein synthesis altogether. It is already known that even under the best of conditions, transcript error rates are orders of magnitude higher than those at the DNA level.

RNA: a string of errors?

While the existence of transcription errors has long been recognized, their quantification has been challenging. The new study describes a clever technique for ferreting out transcription errors caused by mutagens and separating these from experimental artifacts--mutations caused during library preparation of RNA transcripts through processes of reverse-transcription and sequencing.

The method described involves the use of massively parallel sequencing technology to identify only those errors in RNA sequence directly caused by the activity of a mutagen. The results demonstrate that at least some mutagenic compounds are potent sources of both genomic mutations and abundant transcription errors.

The circular sequencing assay outlined in the study creates redundancies in the reverse-transcribed message, providing a means of proofreading the resultant linear DNA. In this way, researchers can confirm that the transcription errors observed are a result of the mutagen's effects on transcription and not an artifact of sample preparation.

The DNA molecule has been shown to be particularly vulnerable to a class of mutagens known as alkylating agents. One of these, known as MNNG, was used to inflict transcriptional errors on the four study organisms. The effects observed were dose-dependent, with higher levels of mutagen causing a corresponding increase in transcriptional errors.

Hidden mistakes may be costly to health

Transcription errors differ from mutations in the genome in at least one vital respect. While DNA replication during cell division acts to amplify mutations to the genome, transcription errors can accumulate in non-dividing cells, with a single mutated DNA template giving rise to multiple abnormal RNA transcripts.

The full effects of these transcription errors on human health remain largely speculative because they have not been amenable to study until now. Using the new technique, researchers can mine the transcriptome--the full library of a living cell's RNA transcripts, searching for errors caused by mutagens.

While the new research offers hope for a more thorough understanding of the relationship between various mutagens and human health, it is also a cautionary tale. A preoccupation with mutational defects in DNA sequence may have blinded science to the potential effects of agents that result in transcription errors without leaving permanent traces in the genome.

This fact raises the possibility that a broad range of environmental factors as well as chemicals and foods deemed safe for human consumption are in need of careful reevaluation based on their potential for producing transcriptional mutagenesis. Further, transcriptional errors in both dividing and non-dividing cell types are likely key players in the complex processes of physical aging and mental decline.

Credit: 
Arizona State University